• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension.

作者信息

Jula A M, Karanko H M

机构信息

Social Insurance Institution, Research and Development Unit, Turku, Finland.

出版信息

Circulation. 1994 Mar;89(3):1023-31. doi: 10.1161/01.cir.89.3.1023.

DOI:10.1161/01.cir.89.3.1023
PMID:8124787
Abstract

BACKGROUND

Cross-sectional studies on human hypertension have suggested an association between sodium intake and left ventricular hypertrophy (LVH).

METHODS AND RESULTS

The effects on LVH of a nonpharmacological treatment program based mainly on sodium restriction were examined by serial echocardiography in a 12-month controlled, randomized study that included 76 previously untreated subjects with uncomplicated mild-to-moderate hypertension. The mean daily sodium excretion of 38 subjects randomized into the treatment group decreased from 195 +/- 95 to 94 +/- 73 mmol (P < .001) at 6 months and to 109 +/- 74 mmol (P < .001) at 12 months. This was accompanied by a weight decrease from 81.4 +/- 18.0 to 79.2 +/- 17.4 kg (P < .001) at 6 months and to 80.6 +/- 17.5 kg (NS) at 12 months. The net blood pressure decrease (difference in change from baseline between the treatment and control groups) was 8.9 mm Hg (P < .001) in systolic blood pressure and 6.5 mm Hg (P < .001) in diastolic blood pressure during the first 6 months and 6.7 mm Hg (P < .01) in systolic blood pressure and 3.8 mm Hg (P < .01) in diastolic blood pressure during the last 6 months. After 12 months of sodium restriction, left ventricular mass (LVM) had decreased by 5.4% (from 238 +/- 63 to 225 +/- 51 g, P < .01), and LVM index (LVMI) had decreased by 4.7% (from 123 +/- 26 to 117 +/- 22 g/m2, P < .05), whereas no changes occurred in these parameters in the control group. In treated subjects with baseline LVMI of more than the median value of 133 g/m2 in men and 107 g/m2 in women, LVM decreased by 8.6% (from 272 +/- 62 to 249 +/- 51 g, P < .01), and LVMI decreased by 7.1% (from 140 +/- 23 to 130 +/- 22 g/m2, P < .01). LVM and LVMI remained unchanged in treated subjects with LVMI values equal to or less than the median.

CONCLUSIONS

Our data suggest that long-term nonpharmacological treatment with moderate sodium restriction decreases LVH.

摘要

相似文献

1
Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension.
Circulation. 1994 Mar;89(3):1023-31. doi: 10.1161/01.cir.89.3.1023.
2
Effects of spironolactone-altizide on left ventricular hypertrophy.螺内酯-阿替洛尔对左心室肥厚的影响。
Acta Cardiol. 1998;53(5):261-7.
3
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.血管紧张素II拮抗剂缬沙坦对原发性高血压患者左心室肥厚的影响。
Circulation. 1998 Nov 10;98(19):2037-42. doi: 10.1161/01.cir.98.19.2037.
4
Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.原发性高血压患者左心室肥厚的消退。吲达帕胺6个月治疗结果
Am J Hypertens. 1996 Aug;9(8):828-32. doi: 10.1016/0895-7061(96)00105-7.
5
Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.动态24小时血压监测：未治疗高血压患者血压变异性与左心室肥厚之间的相关性
G Ital Cardiol. 1998 Jan;28(1):38-44.
6
Relationship between left ventricular mass index and 24-h urinary free cortisol and cortisone in essential arterial hypertension.原发性高血压患者左心室质量指数与24小时尿游离皮质醇及皮质酮的关系
J Hypertens. 1999 Nov;17(11):1583-8. doi: 10.1097/00004872-199917110-00012.
7
Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.比索洛尔与雷米普利治疗高血压伴左心室肥厚患者的比较：一项随机、开放、盲终点（PROBE）试验。
Eur Rev Med Pharmacol Sci. 2011 Dec;15(12):1359-68.
8
Effect of renal artery revascularization on left ventricular hypertrophy, diastolic function, blood pressure, and the one-year outcome.肾动脉血运重建对左心室肥厚、舒张功能、血压和一年预后的影响。
J Vasc Surg. 2011 Mar;53(3):692-7. doi: 10.1016/j.jvs.2010.09.054. Epub 2010 Dec 3.
9
Left Ventricular Mass Reduction by a Low-Sodium Diet in Treated Hypertensive Patients.低盐饮食降低高血压患者左心室质量。
Nutrients. 2020 Nov 30;12(12):3714. doi: 10.3390/nu12123714.
10
Left ventricular mass and subsequent blood pressure changes among middle-aged men in rural and urban Japanese populations.日本城乡中年男性的左心室质量及随后的血压变化
Circulation. 1994 Apr;89(4):1717-24. doi: 10.1161/01.cir.89.4.1717.

引用本文的文献

1
Three-Year Echocardiographic Follow-Up in Outpatients with Systemic Arterial Hypertension: An Observational Cohort Study.系统性动脉高血压门诊患者的三年超声心动图随访：一项观察性队列研究。
J Clin Med. 2025 Aug 17;14(16):5812. doi: 10.3390/jcm14165812.
2
Impact of successful secondary hyperparathyroidism treatment on cardiovascular morbidity in patients with chronic kidney disease KDIGO stages G3b-5.成功治疗继发性甲状旁腺功能亢进对慢性肾脏病KDIGO 3b - 5期患者心血管发病率的影响
Ir J Med Sci. 2024 Dec;193(6):2723-2732. doi: 10.1007/s11845-024-03770-x. Epub 2024 Aug 31.
3
Sodium - a systematic review for Nordic Nutrition Recommendations 2023.
钠——《2023年北欧营养建议》的系统评价
Food Nutr Res. 2024 Jan 31;68. doi: 10.29219/fnr.v68.10319. eCollection 2024.
4
Dietary Salt Restriction and Adherence to the Mediterranean Diet: A Single Way to Reduce Cardiovascular Risk?饮食限盐与坚持地中海饮食：降低心血管风险的单一方法？
J Clin Med. 2024 Jan 16;13(2):486. doi: 10.3390/jcm13020486.
5
Association between lifestyle modifications and improvement of early cardiac damage in children and adolescents with excess weight and/or high blood pressure.生活方式改变与超重和/或高血压的儿童和青少年早期心脏损害改善的相关性。
Pediatr Nephrol. 2023 Dec;38(12):4069-4082. doi: 10.1007/s00467-023-06034-5. Epub 2023 Jun 22.
6
Salt and Gut Microbiota in Heart Failure.盐与心力衰竭中的肠道微生物群。
Curr Hypertens Rep. 2023 Aug;25(8):173-184. doi: 10.1007/s11906-023-01245-5. Epub 2023 May 23.
7
Dietary sodium and health: How much is too much for those with orthostatic disorders?膳食钠与健康：对于患有体位性障碍的人来说，多少算过量？
Auton Neurosci. 2022 Mar;238:102947. doi: 10.1016/j.autneu.2022.102947. Epub 2022 Jan 20.
8
Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies.减少钠摄入对血压的影响：实验研究的剂量反应荟萃分析。
Circulation. 2021 Apr 20;143(16):1542-1567. doi: 10.1161/CIRCULATIONAHA.120.050371. Epub 2021 Feb 15.
9
Sodium Intake and Heart Failure.钠摄入与心力衰竭
Int J Mol Sci. 2020 Dec 13;21(24):9474. doi: 10.3390/ijms21249474.
10
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride.低盐饮食与高盐饮食对血压、肾素、醛固酮、儿茶酚胺、胆固醇和甘油三酯的影响。
Cochrane Database Syst Rev. 2020 Dec 12;12(12):CD004022. doi: 10.1002/14651858.CD004022.pub5.